Nuance Pharma receives Clearance to begin Pivotal Clinical Trials with Ensifentrine for COPD in China

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Related Keywords

United Kingdom ,China ,Taiwan ,Hong Kong ,London ,City Of ,Macau ,Mark Lotter ,Kimberly Minarovich Michael Barron ,David Zaccardelli ,Verona Pharma ,Asia Pacific ,While The Company ,Strategic Communications ,International Media ,Nasdaq ,Nuance Pharma ,Drug Evaluation ,Investigational New Drug ,Greater China ,Nuance Biotech ,Chief Executive Officer ,Kingdom Tel ,Investor Relations ,European Investor Enquiries ,Rebecca Noonan ,Dual Wheel ,Annual Report ,Covid 19 ,Health ,Globe Newswire ,Clinical Trials ,Business ,Chronic Obstructive Pulmonary Disease ,